df7551b0e9bd3d3f…
StudyID:
NCT00117403781 bytesFirst seen Jun 12, 20261 collectionFields
| Name | Value |
|---|---|
| briefSummary | The purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease. The anti-oxidant treatments include vitamin E + C + alpha-lipoic acid, and Coenzyme Q (CoQ). |
| completionDate | 2007-09 |
| conditions | ["Alzheimer's Disease"] |
| enrollmentCount | 75 |
| enrollmentType | ESTIMATED |
| nctId | NCT00117403 |
| phase | PHASE1 |
| sponsorId | national-institute-on-aging-nia |
| startDate | 2006-01 |
| status | COMPLETED |
| studyType | INTERVENTIONAL |
| title | Evaluation of the Safety, Tolerability and Impact on Biomarkers of Anti-Oxidant Treatment of Mild to Moderate Alzheimer's Disease |
| url | https://clinicaltrials.gov/study/NCT00117403 |
Canonical JSON
{
"id": "NCT00117403",
"type": "Study",
"data": {
"briefSummary": "The purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease. The anti-oxidant treatments include vitamin E + C + alpha-lipoic acid, and Coenzyme Q (CoQ).",
"completionDate": "2007-09",
"conditions": [
"Alzheimer's Disease"
],
"enrollmentCount": 75,
"enrollmentType": "ESTIMATED",
"nctId": "NCT00117403",
"phase": "PHASE1",
"sponsorId": "national-institute-on-aging-nia",
"startDate": "2006-01",
"status": "COMPLETED",
"studyType": "INTERVENTIONAL",
"title": "Evaluation of the Safety, Tolerability and Impact on Biomarkers of Anti-Oxidant Treatment of Mild to Moderate Alzheimer's Disease",
"url": "https://clinicaltrials.gov/study/NCT00117403"
}
}Appears in 1 collection
nih/clinical-trials1 version · Jun 12, 2026
Full hash:df7551b0e9bd3d3f6ca464eaebacac75184f2c2ee382fd6880a224aa7b7c1886